Translations:Chronic kidney disease/63/en: Difference between revisions

From Azupedia
Jump to navigation Jump to search
VisualWikitext
FuzzyBot (talk | contribs)
15,166 edits
Importing a new version from external source
 
(No difference)

Latest revision as of 21:51, 25 February 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Chronic kidney disease)
==Research==
Currently, several compounds are in development for the treatment of CKD.  These include the angiotensin receptor blocker (ARB) [[olmesartan medoxomil]]; and [[sulodexide]], a mixture of low molecular weight heparin and dermatan sulfate.

Research

Currently, several compounds are in development for the treatment of CKD. These include the angiotensin receptor blocker (ARB) olmesartan medoxomil; and sulodexide, a mixture of low molecular weight heparin and dermatan sulfate.

Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Chronic_kidney_disease/63/en&oldid=121196"